We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
-2.58%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.9B
AUM Growth
-$125M
Cap. Flow
+$602M
Cap. Flow %
4.04%
Top 10 Hldgs %
16.63%
Holding
1,195
New
6
Increased
170
Reduced
89
Closed
18

Top Buys

Rank Stock Value
1
UCB
United Community Banks
UCB
+$98.2M
2
FLS icon
Flowserve
FLS
+$86.8M
3
SPR
Spirit AeroSystems
SPR
+$82.2M
4
CTS icon
CTS Corp
CTS
+$70M
5
CRL icon
Charles River Laboratories
CRL
+$62.2M

Top Sells

Rank Stock Value
1
VIVO
Meridian Bioscience Inc
VIVO
+$115M
2
MPWR icon
Monolithic Power Systems
MPWR
+$75.3M
3
EBS icon
Emergent Biosolutions
EBS
+$57.3M
4
ON icon
ON Semiconductor
ON
+$28.3M
5
SQM icon
Sociedad Química y Minera de Chile
SQM
+$20.1M

Sector Composition

Rank Sector Weight
1 Financials 20.5%
2 Industrials 19.89%
3 Technology 19.85%
4 Consumer Discretionary 10.32%
5 Healthcare 9.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMCR icon
601
Amcor
AMCR
$20.9B
$9K ﹤0.01%
175
– –
AMP icon
602
Ameriprise Financial
AMP
$48.1B
$9K ﹤0.01%
37
– –
AON icon
603
Aon
AON
$77.8B
$9K ﹤0.01%
33
– –
BALL icon
604
Ball Corp
BALL
$17.4B
$9K ﹤0.01%
186
– –
BBY icon
605
Best Buy
BBY
$18.5B
$9K ﹤0.01%
137
– –
CE icon
606
Celanese
CE
$4.91B
$9K ﹤0.01%
96
– –
DOC icon
607
Healthpeak Properties
DOC
$15.2B
$9K ﹤0.01%
385
– –
DVAX
608
DELISTED
Dynavax Technologies
DVAX
$9K ﹤0.01%
850
– –
EFX icon
609
Equifax
EFX
$20.7B
$9K ﹤0.01%
51
– –
FTV icon
610
Fortive
FTV
$17.7B
$9K ﹤0.01%
196
– –
HUBS icon
611
HubSpot
HUBS
$11.9B
$9K ﹤0.01%
32
– –
IDA icon
612
Idacorp
IDA
$7.86B
$9K ﹤0.01%
89
– –
KDP icon
613
Keurig Dr Pepper
KDP
$43B
$9K ﹤0.01%
245
– –
LEN icon
614
Lennar Class A
LEN
$20.2B
$9K ﹤0.01%
123
– –
PCG icon
615
PG&E
PCG
$39.2B
$9K ﹤0.01%
748
– –
PODD icon
616
Insulet
PODD
$11.5B
$9K ﹤0.01%
39
– –
RPM icon
617
RPM International
RPM
$13.8B
$9K ﹤0.01%
109
– –
SGMA
618
DELISTED
Sigmatron International
SGMA
$9K ﹤0.01%
1,900
– –
WAT icon
619
Waters Corp
WAT
$37.3B
$9K ﹤0.01%
32
– –
ZBH icon
620
Zimmer Biomet
ZBH
$18.4B
$9K ﹤0.01%
90
– –
AMH icon
621
American Homes 4 Rent
AMH
$11.9B
$8K ﹤0.01%
242
– –
APH icon
622
Amphenol
APH
$197B
$8K ﹤0.01%
244
– –
BNS icon
623
Scotiabank
BNS
$107B
$8K ﹤0.01%
161
– –
CBSH icon
624
Commerce Bancshares
CBSH
$8.55B
$8K ﹤0.01%
145
– –
CFG icon
625
Citizens Financial Group
CFG
$30.3B
$8K ﹤0.01%
244
– –
23 24
25
26 27

Similar funds

JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

EARNEST Partners's Q3 2022 Portfolio in Review

As of Q3 2022, EARNEST Partners held 1,195 positions worth $14.9B, down 0.84% from $15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners deployed $602M of net new capital in Q3 2022, opening 6 new positions and adding to 170 existing holdings. Its largest new stake was CTS Corp: 1,744,320 shares worth $72.7M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Meridian Bioscience Inc, an estimated $115M trimmed.

  • EARNEST Partners's largest Q3 2022 buy was CTS Corp: 1,744,320 shares worth $72.7M.
  • EARNEST Partners added most to United Community Banks in Q3 2022, an estimated $98.2M increase.
  • EARNEST Partners's biggest Q3 2022 reduction was Meridian Bioscience Inc, cutting an estimated $115M.
  • EARNEST Partners fully exited Emergent Biosolutions in Q3 2022, selling an estimated $57.3M.
  • EARNEST Partners's ten largest holdings make up 17% of its $14.9B portfolio in Q3 2022.
  • EARNEST Partners opened 6 new positions and closed 18 in Q3 2022.
  • EARNEST Partners's portfolio value fell 0.84% quarter-over-quarter to $14.9B.

Based on EARNEST Partners's 13F filing for Q3 2022, filed 14 Nov 2022.